GORE Tri-Lobe Balloon Catheter BCL2645Recalls & reported problems
W. L. Gore & Associates, Inc. · TRI-LOBE BALLOON CATHETER 26mm - 45mm 18Fr · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 8
- Deaths reported
- 2
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00733132605224), received between Nov 15, 2019 and Apr 2, 2026 — classified as 2 deaths, 6 injuries.
The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem6
- Fluid/Blood Leak1
- Insufficient Device Problem Information1
Patient problems
- Perforation of Vessels2
- Vascular Dissection2
- Aneurysm1
- Ischemia1
- Paresis1
- Rupture1
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
InjuryApr 2, 2026Adverse Event Without Identified Device or Use Problem
THE FOLLOWING WAS REPORTED: ON (B)(6) 2026, THE PATIENT WAS IMPLANTED WITH GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS AORTIC EXTENDER AND GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS) USING A GORE®¿DRYSEAL FLEX INTRODUCER SHEATH AND A GORE® TRI-LOBE BALLOON CATHETER TO TREAT AN ASCENDING THORACIC DISSECTION. REPORTEDLY DURING THE PROCEDURE WHILE RETRACTING THE DELIVERY CATHETER OF THE GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS AORTIC EXTENDER THE DEVICE MOVED DISTALLY AND PARTIALLY COVERED THE INNOMINATE ARTERY. THE PHYSICIAN IMPLANTED A GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS IN THE INNOMINATE ARTERY TO MAINTAIN PATENCY. THEN THE PHYSICIAN IMPLANTED A SECOND GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS AORTIC EXTENDER PROXIMALLY. THE PATIENT TOLERATED THE PROCEDURE. POST PROCEDURE IMAGES REVEALED A TYPE B DISSECTION FROM IMPLANTED GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS AORTIC EXTENDER EXTENDING DOWN INTO THE ILIAC ARTERY. THE PHYSICIAN IS NOT TREATING THE DISSECTION AT THIS TIME. THE EVENT IS ONGOING. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Vascular Dissection
MAUDE report 24770695 ↗InjuryMar 19, 2026Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2026, THE PATIENT UNDERWENT A THORACIC ENDOVASCULAR PROCEDURE TO TREAT A PENETRATING ATHEROSCLEROTIC (PAU) UTILIZING GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS (TBE) AND GORE® TRI-LOBE BALLOON CATHETER. IT WAS REPORTED A TBE AORTIC EXTENDER WAS IMPLANTED AT THE PROXIMAL EDGE OF THE TBE AORTIC COMPONENT. UPON PHYSICIAN BALLOONING THE OVERLAP BETWEEN THE TBE AORTIC COMPONENT AND TBE AORTIC EXTENDER, A LITTLE BIT OF WASTE WAS NOTED ON THE LESSER CURVE OF THE AORTA AND APPEARED TO POP OUT. ALLEGEDLY, THE BALLOON WAS NOTED TO BE FULLY INSIDE THE GRAFT, HOWEVER THE BALLOONING APPEARED TO RUPTURE THE ASCENDING AORTA. IT WAS ALSO REPORTED THE PATIENT CODED AFTER THE BALLOONING WAS PERFORMED, AND WAS CONVERTED TO OPEN HEART REPAIR. THE PATIENT IS ALIVE AND IS ON BYPASS. PHYSICIAN DOES NOT KNOW WHAT CAUSED THIS ISSUE, AS NO EXCESSIVE FORCE WAS USED FOR BALLOONING. NO FURTHER PATIENT INFORMATION IS AVAILABLE.
Patient problems: Perforation of Vessels
MAUDE report 24639195 ↗DeathMar 26, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE FIELD SALES ASSOCIATE REPORTED THE FOLLOWING: ON (B)(6) 2025, THE PATIENT WAS IMPLANTED WITH GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM WITH A GORE® TRI-LOBE BALLOON CATHETER TO TREAT A THORACIC DISSECTION WITH AN INTRAMURAL HEMATOMA PRESENT. IT WAS REPORTED THAT AFTER DEPLOYING THE GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM (TGMR313110/(B)(6), IMAGES REVEALED A PROXIMAL TYPE I ENDOLEAK. THE PHYSICIAN CHOSE TO USE A GORE® TRI-LOBE BALLOON CATHETER TO BALLOON THE ENDOLEAK. REPORTEDLY THE PHYSICIAN WAS ¿AGGRESSIVELY¿ BALLOONING THE PROXIMAL ENDOLEAK AND PERFORATED THE AORTA. WHILE RETRACTING THE BALLOON THE PATIENT CODED. THE PHYSICIAN IMPLANTED AN ADDITIONAL GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM (TGMR313110/(B)(6) TO TREAT THE PERFORATED AORTA. A BLOOD TRANSFUSION WAS REQUIRED. THE PATIENT NEVER RECOVERED FROM THE CODE AND EXPIRED IN THE OPERATING ROOM. REPORTEDLY THE PATIENT HAD A FRIABLE AORTA WITH HISTORY OF CARDIAC ISSUES AND PERIPHERAL VASCULAR DISEASE. DURING THE CODE THE PATIENT DEVELOPED A PLEURAL EFFUSION FROM THE BLEEDING.
Patient problems: Vascular Dissection
MAUDE report 21703660 ↗InjuryAug 8, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2024, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ANEURYSM USING TWO GORE® TAG® CONFORMABLE THORACIC STENT GRAFTS WITH ACTIVE CONTROL SYSTEM AND A GORE® TRI-LOBE BALLOON CATHETER. IT WAS REPORTED THAT THERE WERE NO ISSUES DURING DEVICE PLACEMENT, AND THE PROXIMAL TGMR373715 WAS IMPLANTED JUST DISTAL TO THE PATIENT'S LEFT SUBCLAVIAN ARTERY ORIGIN. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH NO REPORTED ISSUES AND THE PATIENT WAS DOING WELL POST OPERATIVELY. ON (B)(6) 2024, IT WAS REPORTED THAT THE PATIENT HAD DEVELOPED ACUTE LEFT LEG WEAKNESS. A SPINAL DRAIN WAS PLACED AND THE PATIENT WAS ADMITTED TO THE ICU FOR MONITORING. THE SUSPECTED CAUSE OF THE LEFT LEG WEAKNESS REPORTEDLY REMAINS UNKNOWN. NO PATIENT ANATOMY WAS SUSPECTED TO HAVE CAUSED OR CONTRIBUTED TO THE EVENT. THE PATIENT CONTINUES TO BE MONITORED.
Patient problems: Paresis
MAUDE report 19945251 ↗DeathJun 28, 2024Insufficient Device Problem Information; Insufficient Device Problem Information
ON (B)(6) 2024, PATIENT UNDERWENT AN ENDOVASCULAR PROCEDURE TO TREAT A THORACIC ANEURYSM UTILIZING GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS AND GORE® TRI-LOBE BALLOON CATHETER. UPON ATTEMPTING TO BALLOON THE PROXIMAL END OF TAC123715A DEVICE, THE PATIENT'S AORTA RUPTURED. MEDICAL STAFF ATTEMPTED CPR ON THE PATIENT FOR 10 MINUTES, AND ULTIMATELY PATIENT COULD NOT BE REVIVED AND EXPIRED. IT WAS ALSO REPORTED THERE WERE NO ISSUES DURING THE PROCEDURE, WHILE IMPLANTING THE DEVICES. THE BALLOON DID NOT RUPTURE AND WAS NOT OVER INFLATED. IN ADDITION, NO CALCIFICATION WAS NOTED. PHYSICIAN DOES NOT KNOW WHAT CAUSED THIS ISSUE. PHYSICIAN ALSO REPORTS AS PATIENT WAS OLDER, PATIENT PRESENTED WITH A FRAGILE AORTA. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Perforation of Vessels
MAUDE report 19638821 ↗InjuryDec 5, 2023Fluid/Blood Leak; Fluid/Blood Leak
ON (B)(6) 2023, THIS PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR A ZONE 9 INFRARENAL ABDOMINAL AORTIC ANEURYSM AND WAS IMPLANTED WITH GORE® EXCLUDER® AAA ENDOPROSTHESES AND A GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM (CTAG-AC). THE CTAG-AC WAS THE MOST PROXIMAL DEVICE AND WAS DEPLOYED JUST DISTAL TO THE LOWEST RENAL ARTERY WITH THE EXCLUDER TRUNK HAVING BEEN DEPLOYED WITHIN THE CTAG-AC DUE TO THE SIZE OF THE PATIENT AORTA AND THE SIZE OF THE ANEURYSM (7CM). POST DEPLOYMENT OF ALL DEVICES AND ANGIOPLASTY OF ALL THE DEVICES A SMALL PROXIMAL TYPE I ENDOLEAK WAS NOTED. A SECOND BALLOON INFLATION WITH A GORE® TRI-LOBE BALLOON CATHETER (BCL2645/26440564) ENSUED WITH THE TRI-LOBE BALLOON CATHETER UPON WHICH THE PROXIMAL AORTA WAS NOTICED TO HAVE RUPTURED. THE PATIENT WAS CONVERTED TO OPEN WHEREIN ALL THE DEVICES WERE EXPLANTED AND A DACRON GRAFT WAS SEWN INTO THE AORTA. THE PATIENT TOLERATED THE PROCEDURE. THE RUPTURE IS BELIEVED TO HAVE BEEN DUE TO OVERINFLATION OF THE BALLOON DURING ANGIOPLASTY. THE EXPLANTED DEVICES WERE DISCARDED AT THE SITE.
Patient problems: Rupture
MAUDE report 18270481 ↗InjuryOct 12, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2022, THE PATIENT UNDERWENT EMERGENCY TREATMENT OF A SYMPTOMATIC ZONE 0 DISSECTING ANEURYSM USING GORE® TAG® THORACIC BRANCH ENDOPROSTHESES (TBE) AND GORE® TAG® CONFORMABLE THORACIC STENT GRAFTS WITH ACTIVE CONTROL SYSTEM. A GORE® DRYSEAL FLEX INTRODUCER SHEATH AND A GORE® TRI-LOBE BALLOON CATHETER WERE USED AS ACCESSORIES IN THE PROCEDURE. THE PATIENT'S ANATOMY WAS REPORTED TO BE EXTENSIVELY TORTUOUS. ON (B)(6) 2022, THE GORE REPRESENTATIVE WAS MADE AWARE THAT THE PATIENT HAD SPINAL CORD ISCHEMIA WHICH WAS OBSERVED ON THE EVENING OF THE INDEX PROCEDURE. IT WAS REPORTED THAT A NON-PROPHYLACTIC SPINAL DRAIN WAS PLACED POST-PROCEDURE AND A PLAN WAS MADE TO DISCHARGE THE PATIENT TO A REHAB CENTER. THE SPINAL CORD ISCHEMIA IS ONGOING. ON (B)(6) 2022, IT WAS REPORTED THAT THE PATIENT'S SYMPTOMS ARE IMPROVING.
Patient problems: Ischemia
MAUDE report 15592779 ↗InjuryNov 15, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2019, THE PATIENT WAS IMPLANTED WITH CONFORMABLE GORE® TAG® THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEMS (TGMR373715/20930111) WHILE UTILIZING A GORE® TRI-LOBE BALLOON CATHETER (BCL2645/18292403). IT WAS REPORTED THE PATIENTS DESCENDING THORACIC AORTA RUPTURED WHEN BALLOONED AT THE DISTAL DEVICE. WE EXTENDED THE RUPTURED AREA WITH ANOTHER 37X15 DEVICE. ALL SUBSEQUENT AORTA GRAMS SHOWED NO LEAK, HOWEVER, PATIENT¿S PRESSURE IS STILL BEING ACTIVELY MANAGED. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Aneurysm
MAUDE report 9331903 ↗
Other CATHETER, PERCUTANEOUS devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page